CompletedNot Applicable

Comparison of Two Peripheral Inserted Intravenous Catheters

Denmark304 participantsStarted 2018-10-07

Plain-language summary

Central venous catheters are routinely used, however, with a complication rate exceeding 15%. Therefore, other types of venous catheters have been introduced such as a midline catheter. The purpose of the present study is to assess the efficacy and the safety of midline catheters compared to the standard care being a central catheter also inserted peripherally. Patients with indication for intravenous fluids or medicines for 5 to 28 days will be included in the study.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Indication for intravenous medicine or fluids included in the following: * Blood products, isotonic saline- or glucose-solutions (including glucose-insulin-potassium-solutions) * Antibiotics (penicillins, cephalosporins, carbapenems or fluoroquinolones) * Chemotherapy registered for use in a peripheral vein catheter * Expected indication for intravenous access in 5 to 28 days * Informed consent Exclusion Criteria: * Infection or burns at both upper extremities (Involving the area of puncture site) * Pregnancy (Confirmed by positive urine human gonadotropin (hCG) or plasma-hCG) * A central venous catheter already in place (Self-explanatory) * Earlier randomized to the study (Self-explanatory)

What they're measuring

Number of catheter related blood infection

Timeframe: Up to 28 days

Trial details

NCT IDNCT04140916

SponsorAalborg University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Catheter-Related Infections trials